跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 86 条关于
“OMA1-ATF4”
全部
86
临床试验
58
药物
15
机构
2
资讯
11
9个月前
Bantam Pharmaceutical Initiates First-in-Class BTM-3566 Phase 1 Trial for Aggressive Cancers
5个月前
PRMT5 Inhibition Sensitizes B-Cell Lymphoma to Ferroptosis via ATF5-SLC7A11 Axis
去年
DNL343 Shows Promise as First-in-Class eIF2B Activator for ALS Treatment in Phase 1 Clinical Trial
去年
Bantam Pharmaceutical Initiates Phase 1 Trial of Novel Mitochondrial-Targeting Cancer Drug at MD Anderson
3个月前
Notch2 and CXCR4 Identified as Key Drivers of Breast Cancer Dormancy in Bone Marrow
2个月前
Oman Moves Closer to Adopting National Biotechnology Strategy
去年
Oman Achieves Medical Milestone with First Successful CAR-T Cell Therapy Implementation
7个月前
Sinovac Secures Exclusive Hepatitis A Vaccine Contract in Oman, Breaking Into GCC Market
上个月
Mitochondrial Protein OPA1 Deficiency Drives Sex-Specific Fat Intake and Obesity, Study Finds
8个月前
Human Continuum Appoints Dr. Omar Khalid Sial as Chief Scientific Officer to Advance Exosome-Based Therapeutics Platform
第 1 页,共 2 页
上一页
下一页